Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease.

[1]  H. Gendelman,et al.  Proteomic studies of nitrated alpha-synuclein microglia regulation by CD4+CD25+ T cells. , 2009, Journal of proteome research.

[2]  H. Gendelman,et al.  Nitrated α-Synuclein-Induced Alterations in Microglial Immunity Are Regulated by CD4+ T Cell Subsets1 , 2009, The Journal of Immunology.

[3]  H. Gendelman,et al.  Neuromodulatory Activities of CD4+CD25+ Regulatory T Cells in a Murine Model of HIV-1-Associated Neurodegeneration1 , 2009, The Journal of Immunology.

[4]  H. Gendelman,et al.  Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice , 2008, PloS one.

[5]  D. Vignali,et al.  How regulatory T cells work , 2008, Nature Reviews Immunology.

[6]  A. Yoshimura,et al.  Foxp3 Inhibits RORγt-mediated IL-17A mRNA Transcription through Direct Interaction with RORγt*♦ , 2008, Journal of Biological Chemistry.

[7]  H. Fujii,et al.  CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer , 2008, International journal of cancer.

[8]  K. Becker,et al.  Induction of Immunologic Tolerance to Myelin Basic Protein Prevents Central Nervous System Autoimmunity and Improves Outcome After Stroke , 2008, Stroke.

[9]  S. Romagnani,et al.  Human Th17 cells , 2008, Arthritis research & therapy.

[10]  P. Henricks,et al.  1α,25-Dihydroxyvitamin D3 Potentiates the Beneficial Effects of Allergen Immunotherapy in a Mouse Model of Allergic Asthma: Role for IL-10 and TGF-β1 , 2008, The Journal of Immunology.

[11]  D. Keskin,et al.  Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice , 2008, Proceedings of the National Academy of Sciences.

[12]  L. Zitvogel,et al.  Regulatory T Cells Control Dendritic Cell/NK Cell Cross-Talk in Lymph Nodes at the Steady State by Inhibiting CD4+ Self-Reactive T Cells , 2008, The Journal of Immunology.

[13]  J. Kipnis,et al.  Neuroprotective Immunity: T Cell-Derived Glutamate Endows Astrocytes with a Neuroprotective Phenotype , 2008, The Journal of Immunology.

[14]  Qizhi Tang,et al.  The Foxp3+ regulatory T cell: a jack of all trades, master of regulation , 2008, Nature Immunology.

[15]  G. Kaiko,et al.  Immunological decision‐making: how does the immune system decide to mount a helper T‐cell response? , 2008, Immunology.

[16]  H. Gendelman,et al.  Nitrated Alpha-Synuclein and Microglial Neuroregulatory Activities , 2008, Journal of Neuroimmune Pharmacology.

[17]  M. Hensel,et al.  Specific recruitment of regulatory T cells into the CSF in lymphomatous and carcinomatous meningitis. , 2008, Blood.

[18]  H. Gendelman,et al.  Modulation of innate immunity by copolymer‐1 leads to neuroprotection in murine HIV‐1 encephalitis , 2008, Glia.

[19]  S. John,et al.  CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages , 2007, Proceedings of the National Academy of Sciences.

[20]  Ying Zhang,et al.  Abnormality of circulating CD4+CD25+ regulatory T cell in patients with Guillain–Barré syndrome , 2007, Journal of Neuroimmunology.

[21]  S. Ishihara,et al.  CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation–mediated apoptosis of effector CD4+ T cells , 2007, Nature Immunology.

[22]  C. Martínez,et al.  Vasoactive Intestinal Peptide Regulates Th17 Function in Autoimmune Inflammation , 2007, Neuroimmunomodulation.

[23]  D. Littman,et al.  Transcriptional regulation of Th17 cell differentiation. , 2007, Seminars in immunology.

[24]  H. Gendelman,et al.  Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson’s disease , 2007 .

[25]  Y. Belkaid.  Regulatory T cells and infection: a dangerous necessity , 2007, Nature Reviews Immunology.

[26]  U. Grohmann,et al.  IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-κB activation , 2007, Nature Reviews Immunology.

[27]  B. Baban,et al.  Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. , 2007, The Journal of clinical investigation.

[28]  Kathleen M. Smith,et al.  Development, cytokine profile and function of human interleukin 17–producing helper T cells , 2007, Nature Immunology.

[29]  L. Cosmi,et al.  Phenotypic and functional features of human Th17 cells , 2007, The Journal of experimental medicine.

[30]  F. Sallusto,et al.  Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cells , 2007, Nature Immunology.

[31]  J. Kipnis,et al.  Bacterial DNA confers neuroprotection after optic nerve injury by suppressing CD4+CD25+ regulatory T-cell activity. , 2007, Investigative ophthalmology & visual science.

[32]  H. Hartung,et al.  Limited effects of glatiramer acetate in the high-copy number hSOD1-G93A mouse model of ALS , 2007, Experimental Neurology.

[33]  Y. Wan,et al.  Regulatory T Cells, Transforming Growth Factor–β, and Immune Suppression , 2007 .

[34]  Zheng Zhang,et al.  Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. , 2007, Gastroenterology.

[35]  V. Kuchroo,et al.  Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation , 2007, Nature Medicine.

[36]  H. Gendelman,et al.  Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS , 2007, Neurobiology of Disease.

[37]  P. Popovich,et al.  Central nervous system and non‐central nervous system antigen vaccines exacerbate neuropathology caused by nerve injury , 2007, The European journal of neuroscience.

[38]  J. Coombes,et al.  Control of intestinal homeostasis by regulatory T cells and dendritic cells. , 2007, Seminars in immunology.

[39]  Wu Yun,et al.  A study of associated cell-mediated immune mechanisms in experimental autoimmune neuritis rats , 2007, Journal of Neuroimmunology.

[40]  R. Lechler,et al.  Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. , 2007, Blood.

[41]  H. Gendelman,et al.  CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease , 2007, Journal of Neuroimmunology.

[42]  A. Lovett-racke,et al.  T-bet Regulates the Fate of Th1 and Th17 Lymphocytes in Autoimmunity1 , 2007, The Journal of Immunology.

[43]  Yaniv Ziv,et al.  A Novel Immune-Based Therapy for Stroke Induces Neuroprotection and Supports Neurogenesis , 2007, Stroke.

[44]  H. Gendelman,et al.  Glatiramer acetate immunization induces specific antibody and cytokine responses in ALS patients , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[45]  P. Popovich,et al.  Spinal cord injury triggers systemic autoimmunity: evidence for chronic B lymphocyte activation and lupus‐like autoantibody synthesis , 2006, Journal of neurochemistry.

[46]  W. Powell,et al.  Human CD4+CD25+ Regulatory T Lymphocytes Inhibit Lipopolysaccharide-Induced Monocyte Survival through a Fas/Fas Ligand-Dependent Mechanism1 , 2006, The Journal of Immunology.

[47]  R. Gold,et al.  Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis. , 2006, Brain : a journal of neurology.

[48]  D. Littman,et al.  The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells , 2006, Cell.

[49]  H. Fujii,et al.  CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers , 2006, Cancer Immunology, Immunotherapy.

[50]  R. Liblau,et al.  Pertussis Toxin Reduces the Number of Splenic Foxp3+ Regulatory T Cells1 , 2006, The Journal of Immunology.

[51]  Michal Schwartz,et al.  Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Ralph Weissleder,et al.  Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. , 2006, Immunity.

[53]  Javier Martín,et al.  VIP Prevents Experimental Multiple Sclerosis by Downregulating Both Inflammatory and Autoimmune Components of the Disease , 2006, Annals of the New York Academy of Sciences.

[54]  C. Ewen,et al.  A novel mechanism of regulatory T cell-mediated down-regulation of autoimmunity. , 2006, International immunology.

[55]  A. Chorny,et al.  Vasoactive Intestinal Peptide Generates CD4+CD25+ Regulatory T Cells in vivo , 2006, Annals of the New York Academy of Sciences.

[56]  J. Bluestone,et al.  Plasmacytoid DCs and Treg cells: casual acquaintance or monogamous relationship? , 2006, Nature Immunology.

[57]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[58]  A. Chorny,et al.  Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response. , 2006, Blood.

[59]  A. Chorny,et al.  Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells. , 2006, Blood.

[60]  Javier Martín,et al.  Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: down-regulation of inflammatory and autoimmune responses. , 2006, The American journal of pathology.

[61]  A. Chorny,et al.  Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis. , 2006, Arthritis and rheumatism.

[62]  R. J. Hocking,et al.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. , 2006, Immunity.

[63]  A. Chorny,et al.  Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis , 2006, European journal of immunology.

[64]  D. Robinson,et al.  Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent , 2005, The Journal of experimental medicine.

[65]  A. Chorny,et al.  Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo , 2005, Journal of leukocyte biology.

[66]  E. González-Rey,et al.  The Neuropeptide Vasoactive Intestinal Peptide Generates Tolerogenic Dendritic Cells1 , 2005, The Journal of Immunology.

[67]  D. Gray,et al.  CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[68]  P. Krammer,et al.  Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis , 2005, European journal of immunology.

[69]  A. Rudensky,et al.  A function for interleukin 2 in Foxp3-expressing regulatory T cells , 2005, Nature Immunology.

[70]  S. Nish,et al.  CD4+CD25+ Regulatory T Cells Inhibit the Maturation but Not the Initiation of an Autoantibody Response1 , 2005, The Journal of Immunology.

[71]  A. Banham,et al.  Cutting Edge: Direct Suppression of B Cells by CD4+CD25+ Regulatory T Cells1 , 2005, The Journal of Immunology.

[72]  L. A. Stephens,et al.  Natural Recovery and Protection from Autoimmune Encephalomyelitis: Contribution of CD4+CD25+ Regulatory Cells within the Central Nervous System1 , 2005, The Journal of Immunology.

[73]  H. Weiner,et al.  Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease. , 2005, The Journal of clinical investigation.

[74]  S. Ziegler,et al.  Decreased FOXP3 levels in multiple sclerosis patients , 2005, Journal of neuroscience research.

[75]  B. Prabhakar,et al.  IL-10-Producing CD4+CD25+ Regulatory T Cells Play a Critical Role in Granulocyte-Macrophage Colony-Stimulating Factor-Induced Suppression of Experimental Autoimmune Thyroiditis1 , 2005, The Journal of Immunology.

[76]  A. Rudensky,et al.  TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells , 2005, The Journal of experimental medicine.

[77]  P. Popovich,et al.  Inflammatory-mediated injury and repair in the traumatically injured spinal cord. , 2005, Current pharmaceutical design.

[78]  R. Coffman,et al.  T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells , 2005, The Journal of experimental medicine.

[79]  A. Rudensky,et al.  Regulatory T cell lineage specification by the forkhead transcription factor foxp3. , 2005, Immunity.

[80]  David C. Gondek,et al.  Cutting Edge: Contact-Mediated Suppression by CD4+CD25+ Regulatory Cells Involves a Granzyme B-Dependent, Perforin-Independent Mechanism1 , 2005, The Journal of Immunology.

[81]  J. Bluestone,et al.  Achieving Antigen-Specific Tolerance in Diabetes: Regulating Specifically , 2005, International reviews of immunology.

[82]  M. Jordan,et al.  CD4+ CD25+ Regulatory T Cell Selection , 2004, Annals of the New York Academy of Sciences.

[83]  Michal Schwartz,et al.  Vaccination with autoantigen protects against aggregated β‐amyloid and glutamate toxicity by controlling microglia: effect of CD4+CD25+ T cells , 2004, European journal of immunology.

[84]  C. Benoist,et al.  Number of T Reg Cells That Differentiate Does Not Increase upon Encounter of Agonist Ligand on Thymic Epithelial Cells , 2004, The Journal of experimental medicine.

[85]  M. Schwartz,et al.  Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: A dialogue with microglia , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[86]  B. Baban,et al.  Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase. , 2004, International immunology.

[87]  S. Fu,et al.  TGF‐β Induces Foxp3 + T‐Regulatory Cells from CD4 + CD25 − Precursors , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[88]  T. Ley,et al.  Human T regulatory cells can use the perforin pathway to cause autologous target cell death. , 2004, Immunity.

[89]  I. Cohen,et al.  Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies. , 2004, Journal of autoimmunity.

[90]  H. Gendelman,et al.  Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[91]  S. Kaveri,et al.  Cutting Edge: Human CD4+CD25+ T Cells Restrain the Maturation and Antigen-Presenting Function of Dendritic Cells1 , 2004, Journal of Immunology.

[92]  D. Basso,et al.  Passive or Active Immunization with Myelin Basic Protein Impairs Neurological Function and Exacerbates Neuropathology after Spinal Cord Injury in Rats , 2004, The Journal of Neuroscience.

[93]  Clare Baecher-Allan,et al.  Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.

[94]  D. Munn,et al.  Ligation of B7-1/B7-2 by Human CD4+ T Cells Triggers Indoleamine 2,3-Dioxygenase Activity in Dendritic Cells1 , 2004, The Journal of Immunology.

[95]  S. Sakaguchi.  Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. , 2004, Annual review of immunology.

[96]  Shimon Sakaguchi,et al.  IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. , 2004, International immunology.

[97]  Ziv Porat,et al.  Early activation of microglia as antigen-presenting cells correlates with T cell-mediated protection and repair of the injured central nervous system , 2004, Journal of Neuroimmunology.

[98]  Li Li,et al.  Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.

[99]  M. Sela,et al.  Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[100]  M. Sela,et al.  Immunomodulation by the copolymer glatiramer acetate , 2003, Journal of molecular recognition : JMR.

[101]  J. Bluestone,et al.  Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells 1 , 2003, The Journal of Immunology.

[102]  B. Prabhakar,et al.  Selective Induction of Dendritic Cells Using Granulocyte Macrophage-Colony Stimulating Factor, But Not fms-Like Tyrosine Kinase Receptor 3-Ligand, Activates Thyroglobulin-Specific CD4+/CD25+ T Cells and Suppresses Experimental Autoimmune Thyroiditis1 , 2003, The Journal of Immunology.

[103]  M. Delgado,et al.  Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[104]  E. Yoles,et al.  Therapeutic vaccine for acute and chronic motor neuron diseases: Implications for amyotrophic lateral sclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[105]  M. Hart,et al.  Activated/effector CD4+ T cells exacerbate acute damage in the central nervous system following traumatic injury , 2003, Journal of Neuroimmunology.

[106]  K. Wood,et al.  Regulatory lymphocytes: Regulatory T cells in transplantation tolerance , 2003, Nature Reviews Immunology.

[107]  I. Caramalho,et al.  Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by Lipopolysaccharide , 2003, The Journal of experimental medicine.

[108]  Nigel J. Saunders,et al.  CD4+CD25+ TR Cells Suppress Innate Immune Pathology Through Cytokine-dependent Mechanisms , 2003, The Journal of experimental medicine.

[109]  E. Shevach,et al.  The role of suppressor T cells in regulation of immune responses. , 2002, The Journal of allergy and clinical immunology.

[110]  A. Freitas,et al.  Homeostasis of Peripheral CD4+ T Cells: IL-2Rα and IL-2 Shape a Population of Regulatory Cells That Controls CD4+ T Cell Numbers1 , 2002, The Journal of Immunology.

[111]  S. Miller,et al.  EncephalomyelitisExperimental Autoimmune System Inflammation During Active Immune Responses and Central Nervous Cells Suppress Antigen-Specific Autoreactive Regulatory T + CD25+ Cutting Edge: CD4 , 2022 .

[112]  M. Schwartz,et al.  Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity , 2002, Journal of Neuroimmunology.

[113]  L. Cosmi,et al.  Phenotype, Localization, and Mechanism of Suppression of CD4+CD25+ Human Thymocytes , 2002, The Journal of experimental medicine.

[114]  G. Schuler,et al.  Human CD4+CD25+ Regulatory, Contact-dependent T Cells Induce Interleukin 10–producing, Contact-independent Type 1-like Regulatory T Cells , 2002, The Journal of experimental medicine.

[115]  A. Enk,et al.  Infectious Tolerance , 2002, The Journal of experimental medicine.

[116]  L. Klein,et al.  Origin of regulatory T cells with known specificity for antigen , 2002, Nature Immunology.

[117]  Ethan M. Shevach,et al.  Cutting Edge: Depletion of CD4+CD25+ Regulatory T Cells Is Necessary, But Not Sufficient, for Induction of Organ-Specific Autoimmune Disease , 2002, The Journal of Immunology.

[118]  M. Uskoković,et al.  A 1α,25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice , 2002 .

[119]  D. Basso,et al.  Pathological CNS Autoimmune Disease Triggered by Traumatic Spinal Cord Injury: Implications for Autoimmune Vaccine Therapy , 2002, The Journal of Neuroscience.

[120]  J. Shimizu,et al.  Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance , 2002, Nature Immunology.

[121]  K. Mills,et al.  Pathogen-specific T Regulatory 1 Cells Induced in the Respiratory Tract by a Bacterial Molecule that Stimulates Interleukin 10 Production by Dendritic Cells , 2002, The Journal of experimental medicine.

[122]  Y. Lei,et al.  Hyper Immunoglobulin E Response in Mice with Monoclonal Populations of B and T Lymphocytes 〉 , 2001, The Journal of experimental medicine.

[123]  W. Strober,et al.  Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor β , 2001, The Journal of experimental medicine.

[124]  E. Shevach,et al.  Cutting Edge: Control of CD8+ T Cell Activation by CD4+CD25+ Immunoregulatory Cells , 2001, The Journal of Immunology.

[125]  M. Roncarolo,et al.  Human Cd25+Cd4+ T Regulatory Cells Suppress Naive and Memory T Cell Proliferation and Can Be Expanded in Vitro without Loss of Function , 2001, The Journal of experimental medicine.

[126]  H. Weiner,et al.  Protective Autoimmunity Is a Physiological Response to CNS Trauma , 2001, The Journal of Neuroscience.

[127]  R. de Waal Malefyt,et al.  IFN-α and IL-10 Induce the Differentiation of Human Type 1 T Regulatory Cells1 , 2001, The Journal of Immunology.

[128]  Ana Cumano,et al.  CD25+ CD4+ T Cells Regulate the Expansion of Peripheral CD4 T Cells Through the Production of IL-101 , 2001, The Journal of Immunology.

[129]  M. Roncarolo,et al.  Differentiation of T Regulatory Cells by Immature Dendritic Cells , 2001, The Journal of experimental medicine.

[130]  M. Delgado,et al.  VIP and PACAP Enhance the In Vivo Generation of Memory TH2 Cells by Inhibiting Peripheral Deletion of Antigen-Specific Effectors , 2001, Archives of physiology and biochemistry.

[131]  J. Reubi.  In Vitro Evaluation of VIP/PACAP Receptors in Healthy and Diseased Human Tissues: Clinical Implications , 2000, Annals of the New York Academy of Sciences.

[132]  A. Meshorer,et al.  Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[133]  S. Szabo,et al.  Transcriptional regulation of Th1/Th2 polarization. , 2000, Immunology today.

[134]  F. Powrie,et al.  Control of experimental inflammatory bowel disease by regulatory T cells. , 2000, American journal of respiratory and critical care medicine.

[135]  T. Mak,et al.  Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4 , 2000, The Journal of experimental medicine.

[136]  Fiona Powrie,et al.  Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation , 2000, The Journal of experimental medicine.

[137]  I. Bechmann,et al.  Axonal Damage Induced by Invading T Cells in Organotypic Central Nervous System Tissue in vitro: Involvement of Microglial Cells , 2000, Brain pathology.

[138]  M. Schwartz,et al.  T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[139]  H. Hall,et al.  CD4+CD25+ regulatory T cells down‐regulate co‐stimulatory molecules on antigen‐presenting cells , 2000, European journal of immunology.

[140]  S. Sakaguchi.  Regulatory T cells , 2000, Cell.

[141]  J. Bluestone,et al.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. , 2000, Immunity.

[142]  Ethan M. Shevach,et al.  Suppressor Effector Function of CD4+CD25+ Immunoregulatory T Cells Is Antigen Nonspecific , 2000, The Journal of Immunology.

[143]  T. Fujita,et al.  Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. , 1999, Cancer research.

[144]  F. Otsuka,et al.  Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. , 1999, Journal of immunology.

[145]  T. Shimizu,et al.  Roles of tumor necrosis factor-alpha and transforming growth factor-beta in regulating intercellular adhesion molecule-1 expression on murine peritoneal macrophages infected with M. leprae. , 1999, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[146]  M. Delgado,et al.  Regulation of VIP production and secretion by murine lymphocytes , 1999, Journal of Neuroimmunology.

[147]  M. Toda,et al.  Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. , 1998, International immunology.

[148]  Ethan M. Shevach,et al.  CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production , 1998, The Journal of experimental medicine.

[149]  J. Laissue,et al.  Localization of receptors for vasoactive intestinal peptide, somatostatin, and substance P in distinct compartments of human lymphoid organs. , 1998, Blood.

[150]  E. Shevach,et al.  CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. , 1998, Journal of immunology.

[151]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[152]  E. Goetzl,et al.  Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma. , 1997, American journal of respiratory cell and molecular biology.

[153]  P. Pereira,et al.  Establishment of tissue‐specific tolerance is driven by regulatory T cells selected by thymic epithelium , 1996, European journal of immunology.

[154]  R. Coffman,et al.  A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells , 1996, The Journal of experimental medicine.

[155]  A. Coutinho,et al.  Evidence for a Thymus‐Dependent Form of Tolerance that is Not Based on Elimination or Anergy of Reactive T cells , 1996, Immunological reviews.

[156]  A. Coutinho,et al.  A Model for Developmentally Acquired Thymus‐Dependent Tolerance to Central and Peripheral Antigens , 1996, Immunological reviews.

[157]  P. Pereira,et al.  Regulatory T cells in thymic epithelium‐induced tolerance. I. Suppression of mature peripheral non‐tolerant T cells , 1995, European journal of immunology.

[158]  M. Toda,et al.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.

[159]  J. Leceta,et al.  Occurrence of Vasoactive Intestinal Peptide (VIP) in Lymphoid Organs from Rat and Mouse a , 1992, Annals of the New York Academy of Sciences.

[160]  S. Sakaguchi,et al.  Thymus and autoimmunity: capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of autoimmune disease , 1990, The Journal of experimental medicine.

[161]  A. Zapata,et al.  Demonstration of immunoreactive vasoactive intestinal peptide (IR-VIP) and somatostatin (IR-SOM) in rat thymus , 1990, Brain, Behavior, and Immunity.

[162]  A. Coutinho,et al.  Thymic epithelium tolerizes for histocompatibility antigens. , 1990, Science.

[163]  M. Coltey,et al.  Implants of quail thymic epithelium generate permanent tolerance in embryonically constructed quail/chick chimeras. , 1988, Development.

[164]  H. Boehmer,et al.  Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes , 1988, Nature.

[165]  C. Corbel,et al.  Tolerance induced by thymic epithelial grafts in birds. , 1987, Science.

[166]  P. Marrack,et al.  T cell tolerance by clonal elimination in the thymus , 1987, Cell.

[167]  S. Sakaguchi,et al.  Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease , 1985, The Journal of experimental medicine.

[168]  R. Rosenberg,et al.  Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissue. , 1976, Science.

[169]  W. Irvine,et al.  Spontaneous thyroiditis in thymectomized and irradiated Wistar rats. , 1973, Clinical and experimental immunology.

[170]  R. Gershon,et al.  Cell interactions in the induction of tolerance: the role of thymic lymphocytes. , 1970, Immunology.

[171]  M. Schwartz,et al.  Butovsky, O. et al. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc. Natl Acad. Sci. USA 103, 11784-11789 , 2006 .

[172]  M. Číž,et al.  IL-10 does not affect oxidative burst and expression of selected surface antigen on human blood phagocytes in vitro. , 2004, Physiological research.

[173]  Irun R. Cohen,et al.  Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy , 1999, Nature Medicine.

[174]  M. Delgado,et al.  Expression of vasoactive intestinal peptide in lymphocytes: a possible endogenous role in the regulation of the immune system. , 1996, Advances in neuroimmunology.

[175]  M. Cooke,et al.  Self-tolerance checkpoints in B lymphocyte development. , 1995, Advances in immunology.

[176]  B. Bloom,et al.  Stigma variations: observations on suppressor T cells and leprosy. , 1992, Annual review of immunology.

[177]  B. Diamond,et al.  Revisiting and revising suppressor T cells. , 1992, Immunology today.

[178]  D. Green,et al.  Immunoregulatory T-cell pathways. , 1983, Annual review of immunology.

[179]  D. Green,et al.  Discrimination of 2 types of suppressor T cells by cell surface phenotype and by function: the ability to regulate the contrasuppressor circuit. , 1983, The Journal of molecular and cellular immunology : JMCI.

[180]  R. Prehn,et al.  Genetic susceptibility to post-thymectomy autoimmune diseases in mice , 1981, Immunogenetics.